Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
285
datasets available to search
ShareScore release 0.9.0
Dataset results
285 results for “regorafenib”
Regorafenib Post-marketing Surveillance
ClinicalTrials.gov study NCT01843400. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer
ClinicalTrials.gov study NCT05194293. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers
ClinicalTrials.gov study NCT04781192. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Observational Study, Called ROCURS, to Learn About COVID-19 Related Outcomes in People With Cancer Who Are Treated With Tyrosine Kinase Inhibitors (TKIs) Including Regorafenib or Sorafenib
ClinicalTrials.gov study NCT05594147. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Regorafenib in Patients With Advanced Myeloid Malignancies
ClinicalTrials.gov study NCT03042689. IPD Sharing: NO. Countries: 1. Publications: 0.
Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT05770882. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Regorafenib Plus Tislelizumab as First-line Systemic Therapy for Patients With Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT04183088. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib Combined With TAS-102 Versus Regorafenib Monotherapy in Third or Later Line Therapy of mCRC
ClinicalTrials.gov study NCT05970705. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib Plus PD-1 Inhibitor in Patients With Colorectal Cancer
ClinicalTrials.gov study NCT04110093. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib Phase I Study in Mainland Chinese Patients
ClinicalTrials.gov study NCT02398513. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial of Regorafenib in Patients With Pretreated Advanced Melanoma
ClinicalTrials.gov study NCT05370807. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Regorafenib and Sintilimab in Combination with Electroacupuncture in MSS CRC
ClinicalTrials.gov study NCT06456515. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase Ib Study of PDR001 in Combination With Regorafenib in Adult Patients With Previously Treated Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT03081494. IPD Sharing: NO. Countries: 8. Publications: 0.
Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy
ClinicalTrials.gov study NCT05672316. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS
ClinicalTrials.gov study NCT04810182. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitiv
ClinicalTrials.gov study NCT07071961. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Identification of Predictive Biomarker of Regorafenib in Refractory Colorectal Cancer
ClinicalTrials.gov study NCT01996969. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin
ClinicalTrials.gov study NCT01466504. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)
ClinicalTrials.gov study NCT02288078. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients
ClinicalTrials.gov study NCT04698785. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.